Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Brainwell Institute is an independent, Canadian-based dementia-focused think tank and social enterprise. Co-founded in 2024 by neuroscientist Dr. Saskia Sivananthan and research scientist Alexandra Whate, the institute is dedicated to elevating evidence, shaping policy, and driving system-level changes in dementia care and brain health. Funded through its consulting arm, Brainwell Consulting, the institute maintains complete independence from government and corporate funding to deliver unbiased research, public advocacy, and actionable recommendations. Its notable initiatives include the 'Mind the Gap' report on Canadian dementia care and the co-launch of the Ontario Dementia Task Force.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Brainwell Institute.